Literature DB >> 6322676

Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.

T Kesado, K Watanabe, Y Asahi, M Isono, K Ueno.   

Abstract

The in vitro antibacterial activities of the newly developed 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against 67 clinical isolates of Bacteroides fragilis and their resistance to the hydrolytic action of a beta-lactamase produced by B. fragilis were simultaneously compared. The minimal inhibitory concentrations that inhibited 90% of the 7 alpha-methoxy cephalosporins, cefoxitin, cefmetazole, moxalactam, and cefotetan, against the isolates were 4, 8, 8, and 16 micrograms/ml, respectively, and these antibiotics were entirely resistant to hydrolysis by beta-lactamases (0.10 mumol/h per mg of protein) of the isolates. By contrast, 7 beta-methoxyiminoacetamido cephalosporins represented by cefotaxime, ceftizoxime, and cefmenoxime were not effective, as indicated by the minimal inhibitory concentrations that inhibited 90%, 64, 32, and 128 micrograms/ml, respectively. Their antibacterial activities clearly corresponded to their resistance to the hydrolytic action of the beta-lactamase: namely, the correlation coefficients in regression curves of cefotaxime, ceftizoxime, and cefmenoxime, which were expressed by the antibacterial activity (x axis) and the beta-lactamase activity (y axis) were 0.098, 0.034, and 0.163, respectively.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322676      PMCID: PMC185451          DOI: 10.1128/AAC.25.1.131

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

2.  beta-Lactamases of subspecies of Bacteroides fragilis.

Authors:  T Leung; J D Williams
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

3.  Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.

Authors:  F A Drasar; W Farrell; A J Howard; C Hince; T Leung; J D Williams
Journal:  J Antimicrob Chemother       Date:  1978-09       Impact factor: 5.790

4.  Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity.

Authors:  B Olsson; C E Nord; T Wadström
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

Review 5.  Cefoxitin, a semi-synthetic cephamycin: a microbiological overview.

Authors:  J Birnbaum; E O Stapley; A K Miller; H Wallick; D Hendlin; H B Woodruff
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

Review 6.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

7.  Anaerobic infections. 1.

Authors:  S L Gorbach; J G Bartlett
Journal:  N Engl J Med       Date:  1974-05-23       Impact factor: 91.245

8.  [Assay methods for beta-lactamase activity and their application (author's transl)].

Authors:  T Sawai; I Takahashi
Journal:  Tanpakushitsu Kakusan Koso       Date:  1978

9.  Beta-lactamase activity in anaerobic bacteria.

Authors:  A E Weinrich; V E Del bene
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

10.  Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic.

Authors:  G Darland; J Birnbaum
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more
  10 in total

1.  National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.

Authors:  W J Brown
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

Review 2.  Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

Authors: 
Journal:  CMAJ       Date:  1990-06-01       Impact factor: 8.262

3.  Macrolide accumulation by Bacteroides fragilis ATCC 25285.

Authors:  Y Muto; K Bandoh; K Watanabe; N Katoh; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

Review 4.  Cephalosporins in surgery. Prophylaxis and therapy.

Authors:  D W McEniry; S L Gorbach
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Richards
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

Review 6.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

7.  In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.

Authors:  V E Del Bene; P J Carek; J A Twitty; L J Burkey
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

8.  Activity of cefmetazole against anaerobic bacteria.

Authors:  N A Cornick; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

9.  In vitro activity of cefbuperazone against Bacteroides spp.

Authors:  M B Dias; N V Jacobus; S L Gorbach; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

Review 10.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.